Cargando…
Tumor monocyte cross talk promotes lymphoma cell resistance to chemotherapy
Autores principales: | Zhang, Zhe (Jenny), Bulur, Peggy A, Gustafson, Michael P, Gastineau, Dennis A, Dietz, Allan B, Lin, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990973/ http://dx.doi.org/10.1186/2051-1426-1-S1-P179 |
Ejemplares similares
-
Lymphoma monocyte crosstalk via HSP27 to promote immune suppression and chemotherapy resistance
por: Zhang, Zhe, et al.
Publicado: (2014) -
Expression profiling of suppressive monocytes (CD14+HLA-DRlow/neg) in cancer patients
por: Cordes, Stefan F, et al.
Publicado: (2013) -
Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance
por: Zhang, Zhe (Jenny), et al.
Publicado: (2015) -
Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress
por: Lin, Yi, et al.
Publicado: (2014) -
A method for non-overlapping identification of human myeloid derived suppressor cells
por: Gustafson, Michael, et al.
Publicado: (2014)